IKKalpha negatively regulates IRF-5 function in a MyD88-TRAF6 pathway
Department of Medicine, Division of Infectious Diseases and Immunology
Humans; I-kappa B Kinase; Inflammation; Interferon Regulatory Factors; Interferon Type I; Myeloid Differentiation Factor 88; Phosphorylation; Protein Binding; *Signal Transduction; TNF Receptor-Associated Factor 6; Ubiquitination
Immunology and Infectious Disease
Transcription factors of IRF family, IRF-3, IRF-5 and IRF-7 play a critical role in the innate antiviral response. In infected cells, IRF-3 and IRF-7 are activated by TBK-1 and IKK epsilon mediated phosphorylation, while the kinase, phosphorylating IRF-5 in the MyD88 signalling pathway has not yet been identified. We now show that IKK alpha phosphorylates IRF-5 and induces formation of IRF-5 dimers, which have been indicative of IRF-5 activation. However, IKK alpha induced IRF-5 phosphorylation exerts inhibitory effect on the transcriptional activation of type 1 interferon and promoters of the inflammatory cytokines. Addressing the molecular mechanism of IKK alpha mediated inhibition of IRF-5 activity, we show that phosphorylation of IRF-5 by IKK alpha inhibits K63 ubiquitination that is essential for IRF-5 activity. Furthermore, we have identified interaction of IRF-5 with alkaline phosphatase, which causes its de-phosphorylation. The observation that MyD88 activated IRF-5 induces expression of alkaline phosphatase suggests that IRF-5 is under autoregulating loop. Thus these completely new observations identify IKK alpha kinase and alkaline phosphatase as negative regulators of IRF-5 activity in MyD88 pathway and implicate their role in the control of the inflammatory response by attenuation of IRF-5 activity.
DOI of Published Version
Cell Signal. 2010 Jan;22(1):117-27. Epub 2009 Sep 25. Link to article on publisher's site
Balkhi, Mumtaz Yaseen; Fitzgerald, Katherine A.; and Pitha, Paula M., "IKKalpha negatively regulates IRF-5 function in a MyD88-TRAF6 pathway" (2010). Infectious Diseases and Immunology Publications and Presentations. 57.